Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Ahmed H. Salem, PhD, FCP

Senior Research Fellow
Abbvie

Ahmed Salem, PhD, FCP is a Senior Research Fellow/ Senor Director of Clinical Pharmacology and Pharmacometrics at Abbvie and an adjunct Professor at University of Minnesota. Dr. Salem is a pharmacist and got his PhD in 2010 from the University of Minnesota with a focus on Pharmacometrics and a minor in Biostatistics. In his industry role, Dr. Salem has led the clinical pharmacology, pharmacometrics and biopharmaceutics strategy of numerous small and large molecules in oncology, immunology, virology and women’s health. He contributed to 14 different FDA and EMA approvals of new drugs, dosage forms or dosage regimens for marketed products. He has over 220 publications with an i-10 index of 110 and H index of 40 and holds 10 patents in the US and EU. He has worked on over 190 Phase I, II and III clinical trials.

The American College of Clinical Pharmacology (ACCP) selected Dr Salem as the 2022 recipient of the prestigious Tanabe Investigator Award. He was also the 2018 recipient of the AAPS High Impact Article Award in addition to other awards and recognition from the IQ-Clinical Pharmacology Leadership Group (CPLG), UMN and AbbVie Inc. He is also a Fellow of ACCP. Dr. Salem has been an invited speaker and chair at multiple conferences such as ASCPT, ACCP, ACoP, FDA/ASCO Dose Optimization Workshop and FDA Accelerating Anticancer Agent Development & Validation (AAADV) workshop. He also recently established a joint industry-academia post-doctoral fellowship in clinical pharmacology and pharmacometrics between Abbvie and University of Minnesota.

Disclosure(s): Abbvie: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentation(s):